Health insurance company Humana (NYSE:HUM) will be reporting results this Wednesday before market hours. Here’s what to look for.
Humana beat analysts’ revenue expectations by 2.1% last quarter, reporting revenues of $32.65 billion, up 11.4% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates but full-year EPS guidance in line with analysts’ estimates. It added 150,000 customers to reach a total of 14.99 million.
Is Humana a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Humana’s revenue to grow 9.8% year on year to $32.06 billion, slowing from the 13.5% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$3.99 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Humana has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.8% on average.
Looking at Humana’s peers in the health insurance providers segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Cigna delivered year-on-year revenue growth of 10.4%, beating analysts’ expectations by 3.8%, and Centene reported revenues up 21.9%, topping estimates by 3%. Cigna traded up 7.5% following the results while Centene was down 4.7%.
Read our full analysis of Cigna’s results here and Centene’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the health insurance providers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.6% on average over the last month. Humana is down 31.4% during the same time and is heading into earnings with an average analyst price target of $282.96 (compared to the current share price of $189.51).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.